drugset / Trial / NCT00384904
Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this clinical research study is to assess the effect of Famotidine given twice daily on Atazanavir administered with Ritonavir in HIV-Infected subjects.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 300 mg | Oral |
| Subject | Famotidine | Other / unclassified | 20 mg | Oral |
| Subject | Famotidine | Other / unclassified | 40 mg | Oral |
| Comparator | Ritonavir | Other / unclassified | 100 mg | Oral |
| Subject | Tenofovir Disproxil Fumrarate | Unknown | 300 mg | Oral |